Impact of Lipoprotein(a) on Macrovascular Complications of Diabetes in a Multiethnic Population in the French Amazon

Table 5

Distribution of the number (No.) of patients with diabetes-related macrovascular complications according to Lp(a) level: analysis at the 500 mg/mL threshold.

	Lpacat 0-500 mg/mL	mg/mL	value	Total
Macrovascular complications		No. (%)
Angina pectoris
Yes	14 (4.09)	8 (4.85)	0.231	22 (4.34)
No	318 (92.98)	156 (94.55)		474 (93.49)
Unknown	10 (2.92)	1 (0.61)		11 (2.17)
AIT
Yes	15 (4.39)	1 (3.66)	0.607	21 (4.15)
No	321 (93.86)	153 (93.29)		474 (93.68)
Unknown	6 (1.75)	5 (3.05)		11 (2.17)
Stroke
Yes	27 (7.89)	17 (10.30)	0.573	44 (8.68)
No	314 (91.81)	147(89.09)		461 (90.93)
Unknown	1 (0.29)	0 (0.61)		2 (0.39)
Arteriopathy
Yes	28 (5.13)	20 (7.73)	0.288	48 (5.97)
No	440 (80.59)	206 (79.84)		646 (80.35)
Unknown	78 (14.29)	32 (12.40)		110 (13.68)